US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Trump's Melding Of Politics, Antitrust Hard To Roll Back No Photo Available

Bryan Koenig

Environmental initiatives, diversity programs, anti-misinformation efforts and gender-affirming care have become central targets for P... (more story)

What's Next After High Court's Medicare Drug Pricing Pass No Photo Available

Yeji Jesse Lee

As the pharmaceutical industry grapples with the U.S. Supreme Court's refusal to hear about the legality of Medicare drug pricing nego... (more story)

New Suits Target Fed. Loan Rule, CVS 340B Rates And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at new lawsuits targeting a U.S. Department of Education rule limiting loans available to students i... (more story)